Ziprasidone HCl hydrate
Ziprazidone is approved for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been proposed that this drug's efficacy in schizophrenia is mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5HT2) antagonism. As with other drugs having efficacy in bipolar disorder, the mechanism of action of ziprasidone in bipolar disorder is unknown.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD580 |
| CAS # | 138982-67-9 (HCl hydrate) |
| Pricing | Customizable size, Inquiry |
| Synonym | Ziprasidone HCl hydrate; CP88059; CP-88059; CP 88059; CP-88,059; CP-88,059-01; CP88059 hydrochloride; Ziprasidone HCl, |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C21H24Cl2N4O2S |
| Molecular Weight | 467.409 |
| Elemental Analysis | C, 53.96; H, 5.18; Cl, 15.17; N, 11.99; O, 6.85; S, 6.86 |
| IUPAC/Chemical Name | 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one Hydrochloride Monohydrate |
| InChi Key | ZCBZSCBNOOIHFP-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2 |
| SMILES Code | O=C1NC2=C(C=C(CCN3CCN(C4=NSC5=C4C=CC=C5)CC3)C(Cl)=C2)C1.[H]Cl.[H]O[H] |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Class-2 | Schizophrenia |
| Availability | 2 Weeks |